Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Positive-Pressure Respiration | 4 | 2018 | 1160 | 0.92 | Why? |
| Erythrocyte Count | 1 | 2018 | 137 | 0.69 | Why? |
| Cardiopulmonary Bypass | 1 | 2018 | 158 | 0.67 | Why? |
| One-Lung Ventilation | 1 | 2018 | 53 | 0.67 | Why? |
| Erythrocyte Transfusion | 2 | 2018 | 386 | 0.65 | Why? |
| Blood Preservation | 1 | 2017 | 191 | 0.61 | Why? |
| Electric Impedance | 1 | 2018 | 283 | 0.60 | Why? |
| Manikins | 1 | 2017 | 466 | 0.56 | Why? |
| Respiratory Mechanics | 1 | 2018 | 585 | 0.51 | Why? |
| Respiration | 1 | 2018 | 729 | 0.51 | Why? |
| Decision Support Systems, Clinical | 1 | 2018 | 551 | 0.49 | Why? |
| Erythrocytes | 1 | 2017 | 617 | 0.45 | Why? |
| Continuous Positive Airway Pressure | 1 | 2018 | 1187 | 0.39 | Why? |
| Blood Transfusion | 1 | 2018 | 1399 | 0.36 | Why? |
| Respiration, Artificial | 6 | 2021 | 22116 | 0.35 | Why? |
| Simulation Training | 1 | 2017 | 957 | 0.34 | Why? |
| Anesthesiology | 1 | 2017 | 1163 | 0.33 | Why? |
| Respiratory Physiological Phenomena | 2 | 2018 | 157 | 0.33 | Why? |
| Cardiac Surgical Procedures | 1 | 2018 | 1931 | 0.29 | Why? |
| Lung | 3 | 2018 | 31049 | 0.28 | Why? |
| Lung Diseases | 1 | 2018 | 2361 | 0.28 | Why? |
| Cannula | 3 | 2018 | 750 | 0.27 | Why? |
| Single-Blind Method | 2 | 2018 | 1283 | 0.27 | Why? |
| Critical Illness | 4 | 2021 | 17281 | 0.26 | Why? |
| Computer Simulation | 1 | 2017 | 4982 | 0.24 | Why? |
| Oxygen Inhalation Therapy | 4 | 2021 | 3629 | 0.23 | Why? |
| Work of Breathing | 2 | 2018 | 86 | 0.22 | Why? |
| Coinfection | 1 | 2021 | 6820 | 0.21 | Why? |
| Respiratory Insufficiency | 5 | 2021 | 7301 | 0.21 | Why? |
| Decision Support Techniques | 2 | 2018 | 903 | 0.21 | Why? |
| Macrophage-1 Antigen | 1 | 2019 | 13 | 0.20 | Why? |
| Hydroxyethyl Starch Derivatives | 1 | 2019 | 22 | 0.20 | Why? |
| Postoperative Complications | 2 | 2018 | 5861 | 0.20 | Why? |
| Chemotaxis, Leukocyte | 1 | 2019 | 82 | 0.19 | Why? |
| Prospective Studies | 12 | 2021 | 43301 | 0.19 | Why? |
| Blood Platelets | 2 | 2020 | 1704 | 0.19 | Why? |
| Forced Expiratory Flow Rates | 1 | 2017 | 9 | 0.18 | Why? |
| Noninvasive Ventilation | 3 | 2021 | 2329 | 0.17 | Why? |
| Patient Comfort | 1 | 2018 | 74 | 0.17 | Why? |
| Respiratory Muscles | 1 | 2018 | 116 | 0.17 | Why? |
| High Fidelity Simulation Training | 1 | 2017 | 44 | 0.17 | Why? |
| Perioperative Care | 2 | 2018 | 1329 | 0.17 | Why? |
| Wound Infection | 1 | 2017 | 66 | 0.16 | Why? |
| Internship and Residency | 1 | 2017 | 4987 | 0.16 | Why? |
| Airway Extubation | 2 | 2018 | 403 | 0.16 | Why? |
| Endometriosis | 1 | 2017 | 130 | 0.15 | Why? |
| Pulmonary Gas Exchange | 1 | 2018 | 414 | 0.14 | Why? |
| Tidal Volume | 1 | 2018 | 565 | 0.14 | Why? |
| Intestinal Diseases | 1 | 2018 | 231 | 0.14 | Why? |
| Cross-Over Studies | 4 | 2018 | 867 | 0.14 | Why? |
| Abdomen | 1 | 2018 | 424 | 0.14 | Why? |
| Heart Injuries | 1 | 2020 | 608 | 0.13 | Why? |
| Knowledge | 1 | 2017 | 452 | 0.13 | Why? |
| Platelet Count | 1 | 2019 | 1381 | 0.13 | Why? |
| Pilot Projects | 3 | 2021 | 5182 | 0.12 | Why? |
| Interferon-alpha | 1 | 2021 | 1442 | 0.12 | Why? |
| Survivors | 2 | 2021 | 2619 | 0.12 | Why? |
| Intensive Care Units | 6 | 2021 | 29594 | 0.11 | Why? |
| Lung Injury | 1 | 2021 | 919 | 0.11 | Why? |
| Time Factors | 4 | 2018 | 31397 | 0.11 | Why? |
| Proteome | 1 | 2021 | 1812 | 0.11 | Why? |
| Italy | 6 | 2020 | 38444 | 0.10 | Why? |
| Hemodynamics | 1 | 2018 | 1562 | 0.10 | Why? |
| Educational Measurement | 1 | 2017 | 930 | 0.10 | Why? |
| Endothelium, Vascular | 1 | 2021 | 1751 | 0.10 | Why? |
| P-Selectin | 2 | 2021 | 224 | 0.10 | Why? |
| Shock, Septic | 1 | 2019 | 1313 | 0.10 | Why? |
| Inflammation Mediators | 1 | 2021 | 2654 | 0.10 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2018 | 10649 | 0.09 | Why? |
| Aged | 17 | 2021 | 215776 | 0.09 | Why? |
| Myocardium | 1 | 2020 | 2323 | 0.09 | Why? |
| Temperature | 1 | 2018 | 2305 | 0.09 | Why? |
| Antihypertensive Agents | 1 | 2020 | 1962 | 0.09 | Why? |
| Female | 20 | 2021 | 380317 | 0.09 | Why? |
| Male | 19 | 2021 | 367725 | 0.08 | Why? |
| Biomarkers | 5 | 2021 | 23361 | 0.08 | Why? |
| Middle Aged | 17 | 2021 | 270681 | 0.08 | Why? |
| Arrhythmias, Cardiac | 1 | 2020 | 2510 | 0.08 | Why? |
| Humans | 26 | 2021 | 930598 | 0.08 | Why? |
| Monitoring, Physiologic | 1 | 2018 | 1956 | 0.08 | Why? |
| Electrocardiography | 1 | 2020 | 3957 | 0.08 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.08 | Why? |
| Blood Coagulation Disorders | 1 | 2019 | 2040 | 0.07 | Why? |
| Intubation, Intratracheal | 1 | 2021 | 3962 | 0.07 | Why? |
| Analysis of Variance | 2 | 2018 | 950 | 0.07 | Why? |
| Patient Discharge | 1 | 2021 | 5696 | 0.07 | Why? |
| Aged, 80 and over | 6 | 2021 | 88759 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.07 | Why? |
| Clinical Competence | 1 | 2017 | 3263 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.06 | Why? |
| Neutrophils | 1 | 2019 | 5476 | 0.06 | Why? |
| Versicans | 1 | 2021 | 25 | 0.06 | Why? |
| E-Selectin | 1 | 2021 | 55 | 0.06 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.06 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.05 | Why? |
| CD40 Ligand | 1 | 2020 | 121 | 0.05 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3832 | 0.05 | Why? |
| Mitogen-Activated Protein Kinases | 1 | 2021 | 126 | 0.05 | Why? |
| Vesicular Transport Proteins | 1 | 2021 | 110 | 0.05 | Why? |
| Elective Surgical Procedures | 1 | 2018 | 5338 | 0.05 | Why? |
| Intercellular Adhesion Molecule-1 | 1 | 2021 | 189 | 0.05 | Why? |
| Fluorescein-5-isothiocyanate | 1 | 2019 | 15 | 0.05 | Why? |
| Quality of Life | 1 | 2021 | 9820 | 0.05 | Why? |
| Hypoxia | 3 | 2021 | 3626 | 0.05 | Why? |
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2019 | 15 | 0.05 | Why? |
| Antigens, Neoplasm | 1 | 2021 | 230 | 0.05 | Why? |
| Platelet Aggregation | 1 | 2020 | 318 | 0.05 | Why? |
| Prognosis | 2 | 2021 | 32490 | 0.04 | Why? |
| Visual Analog Scale | 1 | 2018 | 151 | 0.04 | Why? |
| Acute Kidney Injury | 1 | 2017 | 5762 | 0.04 | Why? |
| Proof of Concept Study | 1 | 2019 | 696 | 0.04 | Why? |
| Case-Control Studies | 3 | 2021 | 17671 | 0.04 | Why? |
| Sample Size | 1 | 2018 | 518 | 0.04 | Why? |
| Immunoglobulins | 1 | 2021 | 811 | 0.04 | Why? |
| Treatment Failure | 1 | 2021 | 2106 | 0.04 | Why? |
| Goals | 1 | 2018 | 335 | 0.04 | Why? |
| Rectum | 1 | 2018 | 495 | 0.03 | Why? |
| Disease Transmission, Infectious | 1 | 2017 | 9044 | 0.03 | Why? |
| Blood Gas Analysis | 1 | 2017 | 893 | 0.03 | Why? |
| Area Under Curve | 1 | 2021 | 2564 | 0.03 | Why? |
| Ventilator Weaning | 1 | 2018 | 536 | 0.03 | Why? |
| Interleukin-8 | 1 | 2019 | 964 | 0.03 | Why? |
| Colon | 1 | 2018 | 669 | 0.03 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2018 | 2437 | 0.03 | Why? |
| Digestive System Surgical Procedures | 1 | 2018 | 677 | 0.03 | Why? |
| Organ Dysfunction Scores | 1 | 2017 | 1475 | 0.03 | Why? |
| Program Evaluation | 1 | 2018 | 1929 | 0.02 | Why? |
| ROC Curve | 1 | 2021 | 6024 | 0.02 | Why? |
| Patient Readmission | 1 | 2018 | 1543 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2018 | 2259 | 0.02 | Why? |
| Adult | 4 | 2018 | 244371 | 0.02 | Why? |
| Recovery of Function | 1 | 2018 | 2461 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| Guidelines as Topic | 1 | 2020 | 2844 | 0.02 | Why? |
| Oxidative Stress | 1 | 2017 | 2050 | 0.02 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.02 | Why? |
| Patient Satisfaction | 1 | 2018 | 2517 | 0.02 | Why? |
| Oxygen | 1 | 2018 | 3715 | 0.02 | Why? |
| Retrospective Studies | 3 | 2020 | 105322 | 0.02 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.01 | Why? |
| Models, Biological | 1 | 2018 | 4907 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.01 | Why? |
| Length of Stay | 1 | 2018 | 11042 | 0.01 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.01 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.01 | Why? |
| Critical Care | 1 | 2017 | 14081 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Young Adult | 1 | 2018 | 93724 | 0.01 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.00 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.00 | Why? |
Volta's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(154)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(152)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_